CELLphenomics and Charles River Announce Agreement, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening
CELLphenomics and Charles River Laboratories International, Inc. (NYSE: CRL) announced an agreement, that provides Charl…
CELLphenomics and Charles River Laboratories International, Inc. (NYSE: CRL) announced an agreement, that provides Charl…
Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved C…
Excellent news and a great honor for Prof. Dr. Jens Förderer, Professor of Innovation and Digitalization at the Technica…
. 5 million euros funding for innovative projects in biomedicine The research projects address the topics: Hepatitis-B…
hte – the high throughput experimentation company was selected by Stanford School of Humanities and Sciences researchers…
DIN e.V. NormenWerk in Berlin played host to a pivotal event on September 29th, where decision-makers and stakeholders i…
The international research network "MiEl" aims to develop novel synthesis technologies that use renewable and sustainabl…
The German Physical Society (Deutsche Physikalische Gesellschaft, DPG) has awarded the 2023 edition of its Technology Tr…
Atomic clocks guarantee unrivalled precision when it comes to tracking time. They help us keep our digital and analogue…
At the traditional BioM end-of-year dinner, this time host Prof. Horst Domdey looked back not only on an eventful year f…